The Wilder lab aims to prevent immune-mediated adverse side effects associated with cytokine therapy by understanding innate immune regulation and developing dynamically controlled therapies.
The Shy Lab employs cutting-edge genome and epigenome engineering techniques to address the current limitations in cell therapy development, manufacture, and delivery.
At the Nicolas-Avila Lab, we explore the mechanisms by which immune cells contribute to tissue function and develop strategies to improve organismal health through immunomodulation.
We study how the innate immune system (the body’s first line of immune defense) evolves to defend us against the vast and fast-changing world of viruses.